Parkinson's disease Nervous System Diseases Parkinson's disease
Conditions
Interventions
After informed consent patients will be randomly divided into two groups with approximately 75 individuals in each group.
1. Standard attendance of outpatients
This group will continue to attend reg
Sponsors
NHS R&D Regional Programme Register - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients attending the movement disorder clinic at Hunters Moor 2. Being treated for Parkinson's and dystonia 3. Informed consent
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of this model of care will be assessed by a number of means including 1. Assessment of disability status measured by a number of appropriate scales 1.1. general practitioner and primary care team satisfaction questionnaires 1.2. comparison of attendances at hospital and general practitioner 1.3. record of complications 1.4. record of drug and other medical management employed during the study period 2. Satisfaction questionnaires will be administered to the patient and carer and their psychological status will also be measured using the General Health Questionnaire. 3. A brief questionnaire will be designed that records the extent and level of knowledge and understanding of the disease and associated disabilities. This questionnaire will be administered to the client and carer. 4. An economic analysis will also be undertaken of the costs involved in both arms of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed